JP2010508818A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508818A5
JP2010508818A5 JP2009535351A JP2009535351A JP2010508818A5 JP 2010508818 A5 JP2010508818 A5 JP 2010508818A5 JP 2009535351 A JP2009535351 A JP 2009535351A JP 2009535351 A JP2009535351 A JP 2009535351A JP 2010508818 A5 JP2010508818 A5 JP 2010508818A5
Authority
JP
Japan
Prior art keywords
cells
cell
composition
solution
trc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009535351A
Other languages
English (en)
Japanese (ja)
Other versions
JP5537153B2 (ja
JP2010508818A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/023302 external-priority patent/WO2008054825A2/en
Publication of JP2010508818A publication Critical patent/JP2010508818A/ja
Publication of JP2010508818A5 publication Critical patent/JP2010508818A5/ja
Application granted granted Critical
Publication of JP5537153B2 publication Critical patent/JP5537153B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009535351A 2006-11-03 2007-11-05 組織修復のための混合細胞集団および細胞処理のための単離技術 Active JP5537153B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85650406P 2006-11-03 2006-11-03
US60/856,504 2006-11-03
US93270207P 2007-06-01 2007-06-01
US60/932,702 2007-06-01
PCT/US2007/023302 WO2008054825A2 (en) 2006-11-03 2007-11-05 Mixed cell populations for tissue repair and separation technique for cell processing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013147587A Division JP5767672B2 (ja) 2006-11-03 2013-07-16 組織修復のための混合細胞集団および細胞処理のための単離技術

Publications (3)

Publication Number Publication Date
JP2010508818A JP2010508818A (ja) 2010-03-25
JP2010508818A5 true JP2010508818A5 (enExample) 2011-11-24
JP5537153B2 JP5537153B2 (ja) 2014-07-02

Family

ID=39344931

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009535351A Active JP5537153B2 (ja) 2006-11-03 2007-11-05 組織修復のための混合細胞集団および細胞処理のための単離技術
JP2013147587A Active JP5767672B2 (ja) 2006-11-03 2013-07-16 組織修復のための混合細胞集団および細胞処理のための単離技術
JP2015033640A Active JP6246754B2 (ja) 2006-11-03 2015-02-24 組織修復のための混合細胞集団および細胞処理のための単離技術
JP2017099578A Pending JP2017141298A (ja) 2006-11-03 2017-05-19 組織修復のための混合細胞集団および細胞処理のための単離技術

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013147587A Active JP5767672B2 (ja) 2006-11-03 2013-07-16 組織修復のための混合細胞集団および細胞処理のための単離技術
JP2015033640A Active JP6246754B2 (ja) 2006-11-03 2015-02-24 組織修復のための混合細胞集団および細胞処理のための単離技術
JP2017099578A Pending JP2017141298A (ja) 2006-11-03 2017-05-19 組織修復のための混合細胞集団および細胞処理のための単離技術

Country Status (10)

Country Link
US (5) US7871605B2 (enExample)
EP (3) EP2086556B1 (enExample)
JP (4) JP5537153B2 (enExample)
AT (1) ATE496627T1 (enExample)
AU (1) AU2007314299B2 (enExample)
CA (2) CA2913024A1 (enExample)
DE (1) DE602007012290D1 (enExample)
DK (2) DK2086556T3 (enExample)
ES (2) ES2362150T3 (enExample)
WO (1) WO2008054825A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7699767B2 (en) * 2002-07-31 2010-04-20 Arryx, Inc. Multiple laminar flow-based particle and cellular separation with laser steering
US11243494B2 (en) 2002-07-31 2022-02-08 Abs Global, Inc. Multiple laminar flow-based particle and cellular separation with laser steering
DE202007002538U1 (de) * 2007-02-21 2007-06-06 Krebs, Torsten Begasungsvorrichtung und -system
EP2578677A1 (en) * 2007-08-09 2013-04-10 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
MX2011001730A (es) 2008-08-14 2011-03-24 Osiris Therapeutics Inc Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales.
WO2010069321A2 (en) * 2008-12-19 2010-06-24 Stobbe Tech A/S Electronically controlled diaphragm pump
NZ599596A (en) * 2009-11-12 2014-01-31 Tengion Inc Rational design of regenerative medicine products
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CA2802203A1 (en) * 2010-06-10 2011-12-15 Aastrom Biosciences, Inc. Compositions and methods of treating no-option critical limb ischemia (cli)
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
US10908066B2 (en) 2010-11-16 2021-02-02 1087 Systems, Inc. Use of vibrational spectroscopy for microfluidic liquid measurement
KR101910685B1 (ko) 2011-04-15 2018-10-22 플루리스템 리미티드 세포 수집 방법 및 시스템
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
EP2710121A1 (en) 2011-05-18 2014-03-26 Aastrom Biosciences, Inc. Mesenchymal stromal cell populations and methods of making same
WO2013036998A1 (en) * 2011-09-13 2013-03-21 The University Of Sydney Treatment of bone diseases
EP2828379A1 (en) * 2012-03-23 2015-01-28 Aastrom Biosciences, Inc. Cell compositions and methods of using same
US20140099292A1 (en) * 2012-03-23 2014-04-10 Aastrom Biosciences, Inc. CD14+ Cell Compositions and Methods of Using Same
US8927278B2 (en) * 2012-09-10 2015-01-06 National Health Research Institutes Method for generating immunomodulatory cells, the cells prepared therefrom, and use thereof
WO2014089397A1 (en) 2012-12-06 2014-06-12 Aastrom Biosciences, Inc. Compositions and methods of treating and preventing pulmonary fibrosis
US8859007B2 (en) * 2013-01-13 2014-10-14 Theracell, Inc. Oxygenated demineralized bone matrix for bone growth
US8961904B2 (en) 2013-07-16 2015-02-24 Premium Genetics (Uk) Ltd. Microfluidic chip
WO2015017500A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11796449B2 (en) 2013-10-30 2023-10-24 Abs Global, Inc. Microfluidic system and method with focused energy apparatus
JP6437261B2 (ja) * 2014-09-26 2018-12-12 Ｐｈｃホールディングス株式会社 液体貯留ユニット及び分注システム
CA2974903A1 (en) * 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Cells with increased immuno-regulatory properties and methods for their use and manufacture
SG11201706777QA (en) 2015-02-19 2017-09-28 Premium Genetics (Uk) Ltd Scanning infrared measurement system
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
BR112018001232A2 (pt) 2015-07-21 2018-09-25 The Children's Medical Center Corporation pd-l1 que expressa células-tronco hematopoéticas e usos
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN108883136A (zh) 2016-02-12 2018-11-23 蓝鸟生物公司 Vcn增强子组合物及其使用方法
KR20250134722A (ko) * 2016-02-12 2025-09-11 블루버드 바이오, 인코포레이티드. Vcn 인핸서 조성물 및 이의 사용 방법
CN108463985B (zh) 2016-10-31 2020-10-27 华为技术有限公司 一种通话处理方法、终端及系统
WO2019060708A1 (en) 2017-09-22 2019-03-28 The Children's Medical Center Corporation TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS
US11028502B2 (en) * 2017-11-02 2021-06-08 Wake Forest University Health Sciences Vascular constructs
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
EP3796998A1 (en) 2018-05-23 2021-03-31 ABS Global, Inc. Systems and methods for particle focusing in microchannels
US20200054788A1 (en) * 2018-08-17 2020-02-20 Vivex Biomedical, Inc. Infused particles
WO2020123524A1 (en) * 2018-12-11 2020-06-18 Erbi Biosystems, Inc. Methods of manufacturing cell based products using small volume perfusion processes
CN113260848B (zh) 2018-12-21 2025-04-01 Abs全球公司 亚群识别的系统和方法
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
EP3955735B1 (en) 2019-04-18 2024-05-22 ABS Global, Inc. System and process for continuous addition of cryoprotectant
JP7481608B2 (ja) * 2019-06-20 2024-05-13 シンフォニアテクノロジー株式会社 細胞培養装置
US11628439B2 (en) 2020-01-13 2023-04-18 Abs Global, Inc. Single-sheath microfluidic chip
CN116368237A (zh) 2020-10-21 2023-06-30 Abs全球股份有限公司 用于处理遗传样本以确定特性或检测污染的方法及系统
WO2022108840A1 (en) 2020-11-23 2022-05-27 Abs Global, Inc. Modular flow cytometry systems and methods of processing samples
USD1118965S1 (en) 2021-11-12 2026-03-17 Abs Global, Inc. Flow cytometry device
CN114457014B (zh) * 2021-12-15 2024-05-17 南京医科大学 骨痂巨噬细胞分离用组合试剂及其应用
US12305376B2 (en) 2023-04-17 2025-05-20 Xmark SP LLC Air admittance valve

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839292B1 (en) 1987-09-11 1994-09-13 Joseph G Cremonese Cell culture flask utilizing membrane barrier
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5763266A (en) 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5605822A (en) 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en) 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US6326198B1 (en) 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6096532A (en) 1995-06-07 2000-08-01 Aastrom Biosciences, Inc. Processor apparatus for use in a system for maintaining and growing biological cells
US5688687A (en) 1995-06-07 1997-11-18 Aastrom Biosciences, Inc. Bioreactor for mammalian cell growth and maintenance
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
US6228635B1 (en) 1995-06-07 2001-05-08 Aastrom Bioscience, Inc. Portable cell growth cassette for use in maintaining and growing biological cells
US5985653A (en) 1995-06-07 1999-11-16 Aastrom Biosciences, Inc. Incubator apparatus for use in a system for maintaining and growing biological cells
DE69739540D1 (de) 1996-04-19 2009-10-01 Osiris Therapeutics Inc Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen
WO1999003973A1 (en) 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
CA2302339A1 (en) 1997-09-20 1999-04-01 Osiris Therapeutics, Inc. Antigen presenting mesenchymal stem cells
US20020034819A1 (en) 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
US6676937B1 (en) 1998-03-09 2004-01-13 Caritas St. Elizabeth's Medical Center Of Boston Inc. Compositions and methods for modulating vascularization
DE69922933T2 (de) 1998-03-13 2005-12-29 Osiris Therapeutics, Inc. Anwendungen für humane nicht autologe, mesenchymale stammzellen
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO1999047163A2 (en) 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
JP2002510655A (ja) 1998-04-03 2002-04-09 オシリス セラピューティクス，インコーポレイテッド 免疫抑制剤としての間葉幹細胞によるｔ細胞応答を阻害する方法とその利用
WO1999061587A1 (en) 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US7097832B1 (en) 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
CA2429502A1 (en) 2000-07-26 2002-01-31 Scimed Life Systems, Inc. Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
US20050226857A1 (en) * 2001-06-01 2005-10-13 Xcyte Therapies, Inc. T cell therapy for the treatment of cachexia and chronic diseases
US20030022210A1 (en) * 2001-06-01 2003-01-30 Mark Bonyhadi T cell induced tissue repair and regeneration
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US20030170238A1 (en) * 2002-03-07 2003-09-11 Gruenberg Micheal L. Re-activated T-cells for adoptive immunotherapy
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
DE102004055615A1 (de) * 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US20080267972A1 (en) * 2005-02-10 2008-10-30 Invitrogen Corporation Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer

Similar Documents

Publication Publication Date Title
JP6246754B2 (ja) 組織修復のための混合細胞集団および細胞処理のための単離技術
CN108671224B (zh) 血小板裂解物的组合物、用途和制备
Bieback et al. Clinical protocols for the isolation and expansion of mesenchymal stromal cells
JP2017165757A (ja) 間葉系間質細胞集団およびそれを作成する方法
JP2013528230A (ja) ノーオプション重症虚血肢（ｃｌｉ）を処置するための組成物および方法
AU2012255112A1 (en) Mesenchymal stromal cell populations and methods of making same
US20160158292A1 (en) Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
AU2013206071B2 (en) Mixed Cell Populations for Tissue Repair and Separation Technique for Cell Processing
AU2016216704A1 (en) Mixed Cell Populations for Tissue Repair and Separation Technique for Cell Processing